United Therapeutics Corp
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of UTHR would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1999) — listing | $748,608 18.4× | $1,094,264 18.5× |
| Year 6 (2004) | $320,767 9.5× | $466,589 9.5× |
| Year 11 (2009) | $152,168 5.8× | $220,857 5.8× |
| Year 16 (2014) | $69,264 3.7× | $100,424 3.7× |
| Year 21 (2019) | $35,164 3.1× | $50,970 3.1× |
| Year 26 (2024) | $6,019 1.7× | $8,810 1.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Silver Spring, Maryland and Research Triangle Park, United States
Popular scenarios with UTHR
For illustration only — not investment advice. Past performance is not indicative of future results.